Stock Research: AtriCure

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

AtriCure

NasdaqGM:ATRC US04963C2098
78
  • Value
    42
  • Growth
    87
  • Safety
    Safety
    44
  • Combined
    67
  • Sentiment
    76
  • 360° View
    360° View
    78
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

AtriCure, Inc. provides technologies for treating atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management. The company operates in the medical device industry. AtriCure's products are used in open-heart and minimally invasive surgical procedures. In the last fiscal year, the company had a market cap of $1,514 million, profits of $348 million, and revenue of $465 million, with 1300 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 78 (better than 78% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock AtriCure are very positive. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for AtriCure. The consolidated Growth Rank has a good rank of 87, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 87% of competitors in the same industry. The consolidated Sentiment Rank also has a good rank of 76, which means that professional investors are more optimistic about the stock than for 76% of alternative investment opportunities. But the consolidated Value Rank has a less desirable rank of 44, which means that the share price of AtriCure is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 56% of alternative stocks in the same industry. Finally, the consolidated Safety Rank has a riskier rank of 42, which means that the company has a financing structure that is riskier than those of 58% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 30-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
44 37 38 17
Growth
87 73 79 85
Safety
Safety
42 67 20 11
Sentiment
76 94 73 56
360° View
360° View
78 98 60 24
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
95 97 59 4
Opinions Change
61 77 50 30
Pro Holdings
n/a 73 55 100
Market Pulse
69 71 87 75
Sentiment
76 94 73 56
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
44 37 38 17
Growth
87 73 79 85
Safety Safety
42 67 20 11
Combined
67 72 32 22
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
56 56 56 26
Price vs. Earnings (P/E)
45 40 45 25
Price vs. Book (P/B)
49 46 55 43
Dividend Yield
1 1 1 1
Value
44 37 38 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
67 64 61 59
Profit Growth
88 48 79 98
Capital Growth
72 64 86 41
Stock Returns
61 71 35 77
Growth
87 73 79 85
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
76 75 58 53
Refinancing
37 34 21 13
Liquidity
24 51 40 34
Safety Safety
42 67 20 11

Similar Stocks

Discover high‑ranked alternatives to AtriCure and broaden your portfolio horizons.

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Cigna

NYSE:CI
Country: USA
Industry: Health Care Services
Size: XX-Large
Full Stock Analysis

TEGNA

NYSE:TGNA
Country: USA
Industry: Broadcasting
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.